Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
Carolina Lavoz, Sandra Rayego‐Mateos, Macarena Orejudo, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 272-272
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Targeting inflammation to treat diabetic kidney disease: the road to 2030
Sandra Rayego‐Mateos, Raúl R. Rodrigues-Díez, Beatriz Fernández‐Fernández, et al.
Kidney International (2022) Vol. 103, Iss. 2, pp. 282-296
Closed Access | Times Cited: 156
Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”
Marta Ruíz-Ortega, Raúl R. Rodrigues-Díez, Carolina Lavoz, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 813-813
Open Access | Times Cited: 108
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
Javier Donate‐Correa, Carla Ferri, Fátima Sánchez-Quintana, et al.
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 93
Renin-angiotensin system and inflammation update
Elena Cantero‐Navarro, Beatriz Fernández‐Fernández, Adrián M. Ramos, et al.
Molecular and Cellular Endocrinology (2021) Vol. 529, pp. 111254-111254
Closed Access | Times Cited: 78
Diabetic complications and prospective immunotherapy
Lewis Reynolds, Zhengkang Luo, K. N. Singh
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
Julio M. Martínez‐Moreno, Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4113-4113
Open Access | Times Cited: 54
Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control
Tsvetelina Velikova, Plamena Kabakchieva, Yavor Assyov, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 50
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
Reza Elahi, Mahdis Nazari, Vahid Mohammadi, et al.
Molecular Immunology (2024) Vol. 171, pp. 66-76
Open Access | Times Cited: 8
Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis
Flavia Trionfetti, Vanessa Marchant, Guadalupe Tirma González-Mateo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5763-5763
Open Access | Times Cited: 16
Ixekizumab May Improve Renal Function in Psoriasis
Giuseppe Fabrizio Amoruso, Steven Paul Nisticò, Luigi Francesco Iannone, et al.
Healthcare (2021) Vol. 9, Iss. 5, pp. 543-543
Open Access | Times Cited: 32
Anti-IL17A Halts the Onset of Diabetic Retinopathy in Type I and II Diabetic Mice
Amy Y. Zhou, Brooklyn E. Taylor, Katherine G. Barber, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1347-1347
Open Access | Times Cited: 10
Modified Hu-Lu-Ba-Wan Alleviates Early-Stage Diabetic Kidney Disease via Inhibiting Interleukin-17A in Mice
Minmin Gong, Mengdi Zhu, Wenbin Wu, et al.
Chinese Journal of Integrative Medicine (2025)
Closed Access
T helper 17 cells in the pathophysiology of acute and chronic kidney disease
David P. Basile, Md Mahbub Ullah, Jason A. Collet, et al.
Kidney Research and Clinical Practice (2021) Vol. 40, Iss. 1, pp. 12-28
Open Access | Times Cited: 22
<p>lncRNA MEG8 Upregulates miR-770-5p Through Methylation and Promotes Cell Apoptosis in Diabetic Nephropathy</p>
Jinmei Zhang, Liwen Song, Yanjuan Ma, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 2477-2483
Open Access | Times Cited: 20
Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets
Fatemeh Hojjati, Amir Roointan, Alieh Gholaminejad, et al.
Nefrología (English Edition) (2023) Vol. 43, Iss. 5, pp. 575-586
Open Access | Times Cited: 7
Clinical significance of Interleukin 17 receptor E in diabetic nephropathy
Jingjing Wang, Xian Wang, Meixi Wang, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110324-110324
Open Access | Times Cited: 7
Interleukin-17A: Potential mediator and therapeutic target in hypertension
Raúl R. Rodrigues-Díez, Antonio Tejera‐Muñoz, Macarena Orejudo, et al.
Nefrología (English Edition) (2021) Vol. 41, Iss. 3, pp. 244-257
Open Access | Times Cited: 16
Dysregulated miRNA-375, IL-17, TGF-β, and Microminerals Are Associated with Calpain-10 SNP 19 in Diabetic Patients: Correlation with Diabetic Nephropathy Stages
Ghada M. Ezzat, Nashwa Mostafa A. Azoz, Randa A. El Zohne, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17446-17446
Open Access | Times Cited: 6
IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis
Vanessa Marchant, Antonio Tejera‐Muñoz, Laura Márquez‐Expósito, et al.
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1361-1361
Open Access | Times Cited: 16
Contribution of Th17 cells to tissue injury in hypertension
David P. Basile, Justine M. Abais‐Battad, David L. Mattson
Current Opinion in Nephrology & Hypertension (2020) Vol. 30, Iss. 2, pp. 151-158
Open Access | Times Cited: 16
Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes
M. Babul Islam, Utpala Nanda Chowdhury, Zulkar Nain, et al.
Computers in Biology and Medicine (2021) Vol. 136, pp. 104668-104668
Open Access | Times Cited: 13
Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
Jinni Hong, Tingting Fu, Weizhen Liu, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 3707-3725
Open Access | Times Cited: 5
Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets
Fatemeh Hojjati, Amir Roointan, Alieh Gholaminejad, et al.
Nefrología (2022) Vol. 43, Iss. 5, pp. 575-586
Open Access | Times Cited: 9
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
Lucas Opazo-Ríos, Antonio Tejera‐Muñoz, Manuel Soto‐Catalán, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
Reza Elahi, Mahdis Nazari, Vahid Mohammadi, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top